Continuous timely monitoring of core temperature with two wearable devices in pediatric patients undergoing chemotherapy for cancer – a comparison study

Christa Koenig,Roland A. Ammann,Christine Schneider,Johanna Wyss,Jochen Roessler,Eva Brack
DOI: https://doi.org/10.1007/s00520-024-08366-w
IF: 3.1
2024-02-26
Supportive Care in Cancer
Abstract:Pediatric patients with cancer often develop chemotherapy-induced fever in neutropenia (FN), requiring emergency broad-spectrum antibiotics. Continuous temperature monitoring can lead to earlier FN detection and therapy with improved outcomes. We aimed to compare the feasibility of continuous core temperature monitoring with timely data availability between two wearable devices (WDs) in pediatric oncology patients undergoing chemotherapy.
oncology,health care sciences & services,rehabilitation
What problem does this paper attempt to address?
The paper aims to address the issue of chemotherapy-induced fever in neutropenia (FN) in pediatric cancer patients undergoing chemotherapy. FN is a common and potentially life-threatening complication, where fever is often the first and only clinical sign of infection during neutropenia. Therefore, urgent hospitalization and empirical treatment with broad-spectrum antibiotics are required. Time to antibiotic administration (TTA) is often used as a quality of care indicator, as longer TTA is associated with poorer clinical outcomes. Currently, body temperature is usually measured only when fever is suspected, which can lead to treatment delays and adverse outcomes. Continuous core temperature monitoring devices (wearable devices, WDs) can enable timely data acquisition, thereby aiding in early diagnosis, reducing TTA, and ultimately improving the prognosis of FN patients. Additionally, combining other continuously monitored vital sign data can predict impending fever or infection patterns, further reducing TTA. The primary aim of this study is to compare the feasibility of high-quality continuous core temperature monitoring and timely data acquisition using two different wearable devices (CORE® and Everion®) in pediatric cancer patients during chemotherapy. Secondary objectives include comparing the feasibility of monitoring other vital signs, assessing the impact of improved study settings on compliance, exploring patient satisfaction, user-friendliness, and side effects. The study results showed that, after adjustments, CORE® met the predetermined feasibility criteria (15 out of 20 patients), while Everion® nearly met this standard. These findings suggest that continuous high-quality core temperature recording is feasible in chemotherapy patients from preschool to adolescence and encourage the design of randomized controlled trials to further validate the effectiveness of continuous core temperature monitoring.